Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
Clinical trial NCT05809336 · COMPLETED
Trial details
- NCT number
- NCT05809336
- Sponsor
- Beijing Friendship Hospital
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2022-10-31
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.